Efficacy of momordica charantia (bitter melon) supplementation among primary knee osteoarthritis patients : a single-blinded, randomized controlled trial

Introduction: Osteoarthritis (OA) is a common problem affecting the joints in the elderly, and its conservative treatment includes the usage of analgesia, which frequently leads to undesirable side effects. Traditionally, Momordica charantia (MC) or bitter melon is believed to be effective in rel...

Full description

Saved in:

Bibliographic Details
Main Author:	May, Lim Soo
Format:	Thesis
Language:	English
Published:	2018
Subjects:	RC Internal medicine
Online Access:	http://eprints.usm.my/46133/1/Dr.%20Lim%20Soo%20May-24%20pages.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

id	my-usm-ep.46133
record_format	uketd_dc
spelling	my-usm-ep.461332020-02-09T04:22:13Z Efficacy of momordica charantia (bitter melon) supplementation among primary knee osteoarthritis patients : a single-blinded, randomized controlled trial 2018 May, Lim Soo RC Internal medicine Introduction: Osteoarthritis (OA) is a common problem affecting the joints in the elderly, and its conservative treatment includes the usage of analgesia, which frequently leads to undesirable side effects. Traditionally, Momordica charantia (MC) or bitter melon is believed to be effective in relieving pain, including that caused by knee osteoarthritis. Objective: To determine the effects of MC in reducing pain among primary knee osteoarthritis (OA) patients. Methodology: This study involves 75 patients with primary knee osteoarthritis, who were divided into two groups (thirty-eight patients in the MC group and thirty-seven in the placebo group). The patients underwent 3 months daily supplementation of either MC or placebo. Rescue analgesia was allowed as needed, and rescue analgesia intake was recorded. Pain and symptoms during supplementation period were assessed monthly using Knee Injury and Osteoarthritis Outcome Score (KOOS) and EQ-5D-3L (EuroQol- 5 Dimensions- 3 Levels) Health questionnaire. Comparison and analysis between the two groups were done using “repeated measures ANOVA” to determine the changes in KOOS, EQ-5D-3L and analgesic scores after supplementation. Results: After 3 months supplementation period, there were significant improvements in KOOS subscale and EQ-5D-3L score with a reduction in analgesic score. Body weight, BMI and FBS reduced significantly in the MC group. The placebo group had also shown significant improvements in certain KOOS subscale and EQ-5D-3L dimension score, but with increased of analgesic score. Conclusion: Momordica charantia supplementation offers a safe alternative in reducing pain among the primary knee OA patients, while reducing the need for analgesia consumption. These beneficial effects can be seen as early as 3 months of supplementation. 2018 Thesis http://eprints.usm.my/46133/ http://eprints.usm.my/46133/1/Dr.%20Lim%20Soo%20May-24%20pages.pdf application/pdf en public masters Universiti Sains Malaysia Pusat Pengajian Sains Perubatan
institution	Universiti Sains Malaysia
collection	USM Institutional Repository
language	English
topic	RC Internal medicine
spellingShingle	RC Internal medicine May, Lim Soo Efficacy of momordica charantia (bitter melon) supplementation among primary knee osteoarthritis patients : a single-blinded, randomized controlled trial
description	Introduction: Osteoarthritis (OA) is a common problem affecting the joints in the elderly, and its conservative treatment includes the usage of analgesia, which frequently leads to undesirable side effects. Traditionally, Momordica charantia (MC) or bitter melon is believed to be effective in relieving pain, including that caused by knee osteoarthritis. Objective: To determine the effects of MC in reducing pain among primary knee osteoarthritis (OA) patients. Methodology: This study involves 75 patients with primary knee osteoarthritis, who were divided into two groups (thirty-eight patients in the MC group and thirty-seven in the placebo group). The patients underwent 3 months daily supplementation of either MC or placebo. Rescue analgesia was allowed as needed, and rescue analgesia intake was recorded. Pain and symptoms during supplementation period were assessed monthly using Knee Injury and Osteoarthritis Outcome Score (KOOS) and EQ-5D-3L (EuroQol- 5 Dimensions- 3 Levels) Health questionnaire. Comparison and analysis between the two groups were done using “repeated measures ANOVA” to determine the changes in KOOS, EQ-5D-3L and analgesic scores after supplementation. Results: After 3 months supplementation period, there were significant improvements in KOOS subscale and EQ-5D-3L score with a reduction in analgesic score. Body weight, BMI and FBS reduced significantly in the MC group. The placebo group had also shown significant improvements in certain KOOS subscale and EQ-5D-3L dimension score, but with increased of analgesic score. Conclusion: Momordica charantia supplementation offers a safe alternative in reducing pain among the primary knee OA patients, while reducing the need for analgesia consumption. These beneficial effects can be seen as early as 3 months of supplementation.
format	Thesis
qualification_level	Master's degree
author	May, Lim Soo
author_facet	May, Lim Soo
author_sort	May, Lim Soo
title	Efficacy of momordica charantia (bitter melon) supplementation among primary knee osteoarthritis patients : a single-blinded, randomized controlled trial
title_short	Efficacy of momordica charantia (bitter melon) supplementation among primary knee osteoarthritis patients : a single-blinded, randomized controlled trial
title_full	Efficacy of momordica charantia (bitter melon) supplementation among primary knee osteoarthritis patients : a single-blinded, randomized controlled trial
title_fullStr	Efficacy of momordica charantia (bitter melon) supplementation among primary knee osteoarthritis patients : a single-blinded, randomized controlled trial
title_full_unstemmed	Efficacy of momordica charantia (bitter melon) supplementation among primary knee osteoarthritis patients : a single-blinded, randomized controlled trial
title_sort	efficacy of momordica charantia (bitter melon) supplementation among primary knee osteoarthritis patients : a single-blinded, randomized controlled trial
granting_institution	Universiti Sains Malaysia
granting_department	Pusat Pengajian Sains Perubatan
publishDate	2018
url	http://eprints.usm.my/46133/1/Dr.%20Lim%20Soo%20May-24%20pages.pdf
_version_	1747821617262624768

Efficacy of momordica charantia (bitter melon) supplementation among primary knee osteoarthritis patients : a single-blinded, randomized controlled trial

Similar Items